Linda S. Lennox
Public Communications Contact at LANTHEUS HOLDINGS, INC.
Profile
Linda S.
Lennox is currently the Chief of Staff & VP-Corporate Communications at Lantheus Holdings, Inc. Prior to this, she held the position of VP-Investor Relations & Corporate Communications at AMAG Pharmaceuticals, Inc. from 2015 to 2020.
Before that, she was the Vice President-Investor & Media Relations at Critical Therapeutics, Inc. and the Senior Director-Investor Relations at Lantheus Medical Imaging, Inc. Ms. Lennox completed her undergraduate degree at the University of Vermont.
Linda S. Lennox active positions
| Companies | Position | Start |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Public Communications Contact | 2020-07-31 |
Former positions of Linda S. Lennox
| Companies | Position | End |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Investor Relations Contact | 2020-06-30 |
| Critical Therapeutics, Inc. | Public Communications Contact | 2008-11-03 |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Investor Relations Contact | - |
Training of Linda S. Lennox
| University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Linda S. Lennox
